Sun Pharmaceutical Industries has announced the launch of its global innovative drug, Ilumya (tildrakizumab) in India for ...

Dermatologists long reluctant to tackle cutaneous lupus erythematosus may be more open to treating patients with approvals ...

More than 8 million Americans have psoriasis, a chronic autoimmune disorder characterized by patches of sore, itchy, inflamed, or scaly skin, according to the National Psoriasis Foundation (NPF).The ...

Dosing of first MAD cohort in Phase 1 trial of O3R-5671 complete with no drug related adverse events Pharmacokinetic profile demonstrates long ...

Soligenix Inc. (NASDAQ: SNGX) today announces its placement in an editorial published by BioMedWire ("BMW"), one of 75+ brands within the Dynamic Brand Portfolio @ IBN ( InvestorBrandNetwork), a ...

Mycosis fungoides is the most common subtype, making up the vast majority of CTCL cases. While early-stage disease has an estimated five-year survival rate of 88%, it remains a difficult-to-manage ...

Sanofi ( SAN:CA) Evercore 8th Annual Healthcare Conference December 2, 2025 11:30 AM EST Thank you guys for being here. Pleasure to have the CEO of Sanofi, but even more importantly, Chairman-elect of ...

Sun Pharma's subsidiary will invest Rs 3,000 crore in a new manufacturing facility in Madhya Pradesh. The company also ...

LAMPASAS, Texas, Dec. 2, 2025 /PRNewswire/ -- U.S. Dermatology Partners is pleased to announce the opening of its new office in Lampasas, Texas. This is the first dedicated dermatology clinic to serve ...

Indian share markets are trading lower today with the Sensex trading 164 points lower, and Nifty is trading 66 points lower.

Future Market Insights, Inc. (FMI) is an ESOMAR-certified, ISO 9001:2015 market research and consulting organization, trusted by Fortune 500 clients and global enterprises. With operations in the U.S.

And if you're traumatized by other medicated anti-dandruff shampoos in the past, reviewers assure us that, unlike other ...